Purpose:
To assess the outcomes and complications of endotamponade withOxane HD following retinal detachment repair
Methods:
Retrospective case series over a 2-year period looking at allpatients undergoing endotamponade with Oxane HD. Details ofthe patients’ retinal detachment, vitreo-retinal surgery,anatomical reattachment, and complications were gathered.
Results:
Case notes for 10 eyes of 10 patients receiving Oxane HD werereviewed. All were inferior retinal detachments. 3 (30%) weretotal retinal detachments and 7 (70%) had proliferative vitreoretinopathy.Immediately postoperatively, the retina was attached in alleyes. Oxane HD was left in situ for a mean of 23.3 weeks. Themean follow-up duration was 52.2 weeks. 3 eyes (30%) developedlocalised retinal redetachment while the Oxane HD was in situ(noted at 3 weeks, 5 weeks, and 104 weeks respectively). Allthe 3 eyes with direct exchange of perfluorodecalin heavy liquidto Oxane HD intraoperatively developed significant complicationswhile the Oxane HD was in situ. This included persistent uveitis,macular pucker and pseudohypopyon (see Figure). In contrast,the 7 eyes that did not have direct exchange of perfluorodecalinto Oxane HD did not develop any significant complications. Oneeye had retained Oxane HD for more than 2 years (due to initialloss to follow-up), but this seemed to be well tolerated withoutany complications.
Conclusions:
Oxane HD is effective for intraocular endotamponade in the managementof complex retinal detachments. Although it is generally welltolerated, the direct exchange of perflurodecalin heavy liquidwith Oxane HD may be associated with increased risk of complications,and requires further evaluation.
Keywords: retinal detachment • vitreoretinal surgery • proliferative vitreoretinopathy